Deutsche Bank Ag\ T2 Biosystems, Inc. Transaction History

Deutsche Bank Ag\

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 14, 2020	SELL	$0.28 - $1.23 $920 - $4,043	-3,287 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$0.96 - $2.94 $3,155 - $9,663	3,287 New	3,287 $3,000
Q3 2019 Nov 14, 2019	SELL	$0.58 - $3.01 $24,520 - $127,253	-42,277 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$1.47 - $3.16 $4,537 - $9,754	3,087 Added 7.88%	42,277 $70,000
Q1 2019 May 15, 2019	SELL	$2.56 - $4.48 $303,603 - $531,305	-118,595 Reduced 75.16%	39,190 $101,000
Q4 2018 Feb 14, 2019	SELL	$2.98 - $6.86 $1.04 Million - $2.4 Million	-350,306 Reduced 68.95%	157,785 $474,000
Q3 2018 Dec 21, 2021	BUY	$5.36 - $7.83 $2.3 Million - $3.36 Million	429,617 Added 547.46%	508,091 $3.79 Million
Q3 2018 Nov 14, 2018	SELL	$5.36 - $7.83 $1.34 Million - $1.96 Million	-250,506 Reduced 76.15%	78,474 $583,000
Q2 2018 Apr 21, 2020	BUY	$5.97 - $9.58 $49,539 - $79,494	8,298 Added 2.59%	328,980 $2.55 Million
Q2 2018 Aug 14, 2018	BUY	$5.97 - $9.58 $1.72 Million - $2.75 Million	287,332 Added 861.57%	320,682 $2.48 Million
Q1 2018 May 15, 2018	BUY	$4.21 - $7.0 $140,247 - $233,191	33,313 Added 90035.14%	33,350 $216,000
Q3 2017 Nov 14, 2017	BUY	$3.9 - $6.78 $144 - $250	37	37 $0

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $5.99M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.